Epure - another dual listing news. S-chip worth revisiting.

 Epure share price shot up to 90cents this morning (now trading at 88cents, up 5.5cents from yest close) on news of its dual listing in Hong Kong.

This is the 3rd counters that move on dual listing news (previously XLX and Oceanus), and this is likely to be the trend in the near term. Other counters that have similar intentions are Midas, Map Technology, Chiangtian, which have all moved up in recent days as players hype on the "revaluation" story of such corporate actions.

Talk in the market has been that more counters are likely to seek out for such corporate actions as it seek out better valuation in market outside Singapore. In general, I continue to hold the views that such expectation is likely to force a revaluation of S-chip especially those with strong fundamental, since they are likely to be approach for such dual listing action.

Personally, among the S-chips, I favor counters such as Sinomem and Sinotel (which is already on US mkt via ADR). Both are solidly run company with strong management and business. If they can't get the right value here, I am sure they will seek it elsewhere and I am probably not the only one thinking about this.

Sinomem has been testing the 60.5 resistance in recents days, a breakout of this R will likely see it spike up to 64 and above. Immediate support at 58.
Sinotel seems to have broke recent upper trendline, but have to cross 67 for a convincing move upward. Immediate support at 63.

Such counters provide both short term (dual listing play) and long term potential (Business fundamental), hence is worth considering.

Congratulation to those who have believe in my new year rally prediction...and has piled on during the X'mas season. Must buy me lunch ok?

This blog is a selections of my investment views to my client. If you find it useful or have additional information to share, please do let me know. These blogs are my personal views and is not meant to solicit any sales or investment on any securities or investment. I may have vested interest in some of the counters or investment products, hence please invest at your own risk. As usual invest in what you understand and do your own homework as usual.